Literature DB >> 25753900

Frozen section during partial nephrectomy: does it predict positive margins?

Jennifer Gordetsky1, Michael A Gorin2, Joe Canner3, Mark W Ball2, Phillip M Pierorazio2, Mohamad E Allaf2, Jonathan I Epstein2,4.   

Abstract

OBJECTIVE: To investigate the clinical utility of frozen section (FS) analysis performed during partial nephrectomy (PN) and its influence on intra-operative management. PATIENTS AND METHODS: We performed a retrospective analysis of consecutive PN cases from 2010 to 2013. We evaluated the concordance between the intra-operative FS diagnosis and the FS control diagnosis, a postoperative quality assurance measure performed on all FS diagnoses after formalin fixation of the tissue. We also evaluated the concordance between the intra-operative FS diagnosis and the final specimen margin. Operating reports were reviewed for change in intra-operative management for cases with a positive or atypia FS diagnosis, or if the mass was sent for FS.
RESULTS: A total of 576 intra-operative FSs were performed in 351 cases to assess the PN tumour bed margin, 19 (5.4%) of which also had a mass sent for FS to assess the tumour type. The concordance rate between the FS diagnosis and the FS control diagnosis was 98.3%. There were 30 (8.5%) final positive specimen margins, of which four (13.3%) were classified as atypia, 17 (56.7%) as negative and nine (30%) as positive on FS diagnosis. Intra-operative management was influenced in six of nine cases with a positive FS diagnosis and in one of nine cases with an FS diagnosis of atypia.
CONCLUSIONS: The relatively high false-negative rate, controversy over the prognosis of a positive margin, and inconsistency in influencing intra-operative management are arguments against the routine use of FS in PN cases.
© 2014 The Authors BJU International © 2014 BJU International Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  frozen section; margins; partial nephrectomy

Mesh:

Year:  2015        PMID: 25753900     DOI: 10.1111/bju.13011

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  6 in total

Review 1.  Surgical Margins in Nephron-Sparing Surgery for Renal Cell Carcinoma.

Authors:  Dean D Laganosky; Christopher P Filson; Viraj A Master
Journal:  Curr Urol Rep       Date:  2017-01       Impact factor: 3.092

2.  Positive surgical margins are predictors of local recurrence in conservative kidney surgery for pT1 tumors.

Authors:  Patricio Garcia Marchiñena; Sebastián Tirapegui; Ignacio Tobia Gonzalez; Alberto Jurado; Guillermo Gueglio
Journal:  Int Braz J Urol       Date:  2018 May-Jun       Impact factor: 1.541

3.  Investigation of confocal microscopy for differentiation of renal cell carcinoma versus benign tissue. Can an optical biopsy be performed?

Authors:  Michael C Phung; Andrew R Rouse; Jayce Pangilinan; Robert C Bell; Erika R Bracamonte; Sharfuddeen Mashi; Arthur F Gmitro; Benjamin R Lee
Journal:  Asian J Urol       Date:  2019-12-24

Review 4.  Current strategies to diagnose and manage positive surgical margins and local recurrence after partial nephrectomy.

Authors:  Umberto Carbonara; Daniele Amparore; Cosimo Gentile; Riccardo Bertolo; Selcuk Erdem; Alexandre Ingels; Michele Marchioni; Constantijn H J Muselaers; Onder Kara; Laura Marandino; Nicola Pavan; Eduard Roussel; Angela Pecoraro; Fabio Crocerossa; Giuseppe Torre; Riccardo Campi; Pasquale Ditonno
Journal:  Asian J Urol       Date:  2022-06-14

5.  Outcomes of Nephron Sparing in a Specialist Cancer Hospital of a Developing Country.

Authors:  Muhammad Arshad Irshad Khalil; Nouman Khan; Azfar Ali; Muhammad Abu Bakar; Siddique Adnan; Shaukat Fiaz; Aleena Akbar Khan; Khurram Mir
Journal:  Cureus       Date:  2019-02-27

6.  Impact of Positive Surgical Margins After Partial Nephrectomy.

Authors:  João André Mendes Carvalho; Pedro Nunes; Edgar Tavares-da-Silva; Belmiro Parada; Roberto Jarimba; Pedro Moreira; Edson Retroz; Rui Caetano; Vítor Sousa; Augusta Cipriano; Arnaldo Figueiredo
Journal:  Eur Urol Open Sci       Date:  2020-10-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.